EE03687B1 - Furandiarylmethylidene derivatives, method of their preparation and use in therapy - Google Patents
Furandiarylmethylidene derivatives, method of their preparation and use in therapyInfo
- Publication number
- EE03687B1 EE03687B1 EE9800333A EE9800333A EE03687B1 EE 03687 B1 EE03687 B1 EE 03687B1 EE 9800333 A EE9800333 A EE 9800333A EE 9800333 A EE9800333 A EE 9800333A EE 03687 B1 EE03687 B1 EE 03687B1
- Authority
- EE
- Estonia
- Prior art keywords
- furandiarylmethylidene
- therapy
- derivatives
- preparation
- furandiarylmethylidene derivatives
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9604236A FR2747123B1 (en) | 1996-04-04 | 1996-04-04 | NOVEL DIARYLMETHYLIDENE TETRAHYDROFURANE DERIVATIVES, PROCESSES FOR THEIR PREPARATION, AND THERAPEUTIC USES |
| FR9607922A FR2747124B1 (en) | 1996-04-04 | 1996-06-26 | NOVEL FURANIC DIARYLMETHYLIDENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES |
| PCT/FR1997/000602 WO1997037984A1 (en) | 1996-04-04 | 1997-04-03 | Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE9800333A EE9800333A (en) | 1999-04-15 |
| EE03687B1 true EE03687B1 (en) | 2002-04-15 |
Family
ID=9490907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EE9800333A EE03687B1 (en) | 1996-04-04 | 1997-04-03 | Furandiarylmethylidene derivatives, method of their preparation and use in therapy |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP0891345B1 (en) |
| JP (1) | JP2000508638A (en) |
| KR (1) | KR20000005146A (en) |
| CN (1) | CN1215396A (en) |
| AR (1) | AR006539A1 (en) |
| AT (1) | ATE204268T1 (en) |
| AU (1) | AU717146B2 (en) |
| BG (1) | BG62808B1 (en) |
| BR (1) | BR9708510A (en) |
| CA (1) | CA2248949A1 (en) |
| CZ (1) | CZ318898A3 (en) |
| DE (1) | DE69706157T2 (en) |
| DK (1) | DK0891345T3 (en) |
| EE (1) | EE03687B1 (en) |
| ES (1) | ES2162678T3 (en) |
| FR (2) | FR2747123B1 (en) |
| GE (1) | GEP20032924B (en) |
| IL (1) | IL126105A (en) |
| NO (1) | NO984624L (en) |
| NZ (1) | NZ331672A (en) |
| PL (1) | PL329213A1 (en) |
| PT (1) | PT891345E (en) |
| RU (1) | RU2189979C2 (en) |
| SI (1) | SI0891345T1 (en) |
| SK (1) | SK283292B6 (en) |
| TW (1) | TW353660B (en) |
| WO (1) | WO1997037984A1 (en) |
| ZA (1) | ZA972894B (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
| US6026814A (en) | 1997-03-06 | 2000-02-22 | Scimed Life Systems, Inc. | System and method for percutaneous coronary artery bypass |
| WO1998043966A1 (en) * | 1997-04-02 | 1998-10-08 | Merck Frosst Canada & Co. | Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors |
| FR2775477B1 (en) * | 1998-02-27 | 2000-05-19 | Union Pharma Scient Appl | NOVEL HETEROCYCLIC DIARYLMETHYLENE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES |
| CN1106392C (en) * | 2000-10-24 | 2003-04-23 | 中国科学院上海有机化学研究所 | Butenolide containing no substituent at beta position and its synthesis process |
| AR038957A1 (en) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | COMBINATION THERAPY FOR CANCER TREATMENT |
| EP1562930A4 (en) * | 2002-11-05 | 2008-12-10 | Magnachem Int Lab Inc | Synthetic lactone formulations and method of use |
| CA2524568C (en) * | 2003-03-31 | 2012-07-17 | Council Of Scientific & Industrial Research | Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof |
| DE602004002832T2 (en) | 2003-05-07 | 2007-06-06 | Osteologix A/S | TREATMENT OF CARTILAGE / BONE DISEASES WITH WATER-SOLUBLE STRONTIUM SALTS |
| US8779168B2 (en) * | 2010-12-16 | 2014-07-15 | Transitions Optical, Inc. | Lactone compounds and materials made therefrom |
| WO2022195579A1 (en) | 2021-03-15 | 2022-09-22 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2111288T3 (en) * | 1993-01-15 | 1998-03-01 | Searle & Co | NEW 3,4-DIARYL THIOPHENES AND ANALOGS OF THE SAME USEFUL AS ANTI-INFLAMMATORY AGENTS. |
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| IL112249A (en) * | 1994-01-25 | 2001-11-25 | Warner Lambert Co | Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds |
| US5585504A (en) * | 1994-09-16 | 1996-12-17 | Merck & Co., Inc. | Process of making cox-2 inhibitors having a lactone bridge |
-
1996
- 1996-04-04 FR FR9604236A patent/FR2747123B1/en not_active Expired - Fee Related
- 1996-06-26 FR FR9607922A patent/FR2747124B1/en not_active Expired - Lifetime
-
1997
- 1997-03-24 TW TW086103701A patent/TW353660B/en active
- 1997-04-03 NZ NZ331672A patent/NZ331672A/en unknown
- 1997-04-03 KR KR1019980707808A patent/KR20000005146A/en not_active Ceased
- 1997-04-03 AT AT97919476T patent/ATE204268T1/en active
- 1997-04-03 EP EP97919476A patent/EP0891345B1/en not_active Expired - Lifetime
- 1997-04-03 IL IL12610597A patent/IL126105A/en not_active IP Right Cessation
- 1997-04-03 AU AU23933/97A patent/AU717146B2/en not_active Ceased
- 1997-04-03 JP JP9535910A patent/JP2000508638A/en active Pending
- 1997-04-03 CA CA002248949A patent/CA2248949A1/en not_active Abandoned
- 1997-04-03 CN CN97193543A patent/CN1215396A/en active Pending
- 1997-04-03 WO PCT/FR1997/000602 patent/WO1997037984A1/en not_active Ceased
- 1997-04-03 CZ CZ983188A patent/CZ318898A3/en unknown
- 1997-04-03 DE DE69706157T patent/DE69706157T2/en not_active Expired - Lifetime
- 1997-04-03 GE GEAP19974555A patent/GEP20032924B/en unknown
- 1997-04-03 PT PT97919476T patent/PT891345E/en unknown
- 1997-04-03 BR BR9708510A patent/BR9708510A/en not_active IP Right Cessation
- 1997-04-03 ES ES97919476T patent/ES2162678T3/en not_active Expired - Lifetime
- 1997-04-03 DK DK97919476T patent/DK0891345T3/en active
- 1997-04-03 SI SI9730222T patent/SI0891345T1/en unknown
- 1997-04-03 PL PL97329213A patent/PL329213A1/en unknown
- 1997-04-03 SK SK1375-98A patent/SK283292B6/en not_active IP Right Cessation
- 1997-04-03 EE EE9800333A patent/EE03687B1/en unknown
- 1997-04-03 RU RU98119887/04A patent/RU2189979C2/en not_active IP Right Cessation
- 1997-04-04 ZA ZA9702894A patent/ZA972894B/en unknown
- 1997-04-04 AR ARP970101359A patent/AR006539A1/en not_active Application Discontinuation
-
1998
- 1998-09-16 BG BG102771A patent/BG62808B1/en unknown
- 1998-10-02 NO NO984624A patent/NO984624L/en not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI955235A7 (en) | Oxazolidinion derivatives, their preparation and use | |
| EE9800459A (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| EE9600172A (en) | Purin-6-one derivatives, their preparation method, use in the preparation of medicaments and medicaments | |
| EE9700039A (en) | Spiro-azabicyclic compounds used in therapy and their preparation process | |
| FI934220A7 (en) | Piperidine derivatives, their preparation and their use in therapy | |
| FI962927A7 (en) | Tetracycline derivatives, preparation method and use | |
| FI951468A7 (en) | Lipopeptide derivatives, method for their preparation and use | |
| EE9700145A (en) | Cycloalkanepyridines, their method of preparation, their use in the manufacture of medicinal products and medicinal products containing these compounds | |
| FI944600L (en) | Imidazol-4-ylpiperidine derivatives, their preparation and their use in therapy | |
| FI954763A7 (en) | Auxin derivatives, their preparation and their therapeutic use | |
| FI955906A7 (en) | O6-substituted guanine derivatives, method for their preparation and their use in the treatment of tumor cells | |
| EE9700288A (en) | Azacycloalkane derivatives, their preparation and use in therapy | |
| EE9900155A (en) | 1H-pyrido [3,4-b] indole-4-carboxamide derivatives, process for their preparation and use in therapy | |
| PL327854A1 (en) | Novel derivatives of benzoguanidin, method of obtaining them and their application in production of therapeutic agents | |
| FI931414A7 (en) | Imidazole derivatives, method for their preparation and their use in therapy | |
| FI951060A7 (en) | Formulations and treatment methods | |
| EE03687B1 (en) | Furandiarylmethylidene derivatives, method of their preparation and use in therapy | |
| EE04317B1 (en) | 4-Oxo-3,5-dihydro-4H-pyridazino [4.5-b] indole-1-ethanamide derivatives, their preparation and their use in therapy | |
| EE9900218A (en) | 1,4-Diazabicyclo [2.2.2] oct-2-ylmethyl benzoate derivatives, their preparation and their use in therapy | |
| EE9800451A (en) | Novel imidazotriazolopyrimidines, their preparation and their use as therapeutic substances | |
| EE200000207A (en) | 8-Azabicyclo [3.2.1] octane-3-methanamine derivatives, their preparation and therapeutic use | |
| EE9900414A (en) | 2,3-dihydrofuro [3,2-b] pyridine derivatives, their preparation and use in therapy | |
| EE9900135A (en) | N- (2-benzothiazolyl) -1-piperidinethanamine derivatives, their preparation and their use in therapy | |
| FI970750L (en) | Indole-2,3-dione-3-oxime derivatives, their preparation and use | |
| FI954141L (en) | Oxazoloquinolone derivatives, their preparation and their use in therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20021231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20031231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20041231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20091231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |